Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment

Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. This morning, Hamilton, Bermuda based biopharmaceutical comp...
Streetwise Reports | April 1, 2020 |

Savara Shares Double After FDA Grants Breakthrough Therapy Status for aPAP Treatment

Shares of Savara opened nearly 140% higher today after the orphan lung disease company advised that the FDA has granted Breakthrough Therapy designation for the firm's Molgradex for treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP). This morning orphan lun...
Streetwise Reports | January 2, 2020 |

Uber's Green Competitor That's Taking The World By Storm

As the global economy faces $1 trillion in damages within five years because of climate change, the explosive ride-sharing business is facing heightened scrutiny as one of the transportation sector's biggest new polluters. So, when a group of tech innovators with a visi...
Meredith Taylor | April 7, 2020 |

Magnesium, This Critical Mineral Opportunity has Nowhere to Go But Up

(Project map via West High Yield Resources.) Investors eyeing opportunities in the hot gold, silver, and rare earth element (REE) markets may have a lot of options, but few check as many boxes as West High Yield Resources Ltd. ( TSX-V: WHY , OTC: WHYRF , ...
Stockhouse Editorial | April 12, 2021 |

Stock Performance in the Rising Coronavirus Fever

The bulls didn’t really get their act together yesterday, and the early gains evaporated a few hours into the session. As stocks closed near their daily lows, what chances of invalidating Tuesday’s breakdown below the important support do the bu...
Monica Kingsley | February 27, 2020 |

Rich TV Live's Stocks to Watch this week (Sept. 20, 2024)

Richard De Sousa of the Rich TV Live podcast serves up his latest Stocks to Watch, exclusively for Stockhouse . De Sousa is pumped about the Fed’s rate cut and stocks such as Mastercard, Netflix, ADMA Biologics, GM, Laser Photonics, Uber and much mo...
Rich TV Live | September 20, 2024 |

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

The importance of health has not been as clear for a long time as it was in 2020. Detached from the discussion about the specifics of COVID-19 on mortality compared to other viruses, the need for protection is great and helplessness without a medical response is harmful to the...
Mario Hose | July 29, 2020 |

Natural gas: Future of the auto industry?

As billionaire T. Boone Pickens and politicians on Capitol Hill debate whether to offer tax credits to help facilitate a transition to natural-gas-fueled trucking fleets, U.S. automakers Chrysler and General Motors ( NYSE: GM , Stock Forum ) are rolling out their own pl...
Robert Ross | October 28, 2012 |

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May

Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expec...
Streetwise Reports | April 9, 2020 |

Blacktop politics

Benjamin Franklin once said; “Out of adversity comes opportunity.” The adversity the United States now faces with the coronavirus pandemic is the worst national emergency the country has faced since World War II, more serious, far more deadly, than a...
Richard (Rick) Mills | April 3, 2020 |
1 2 3 4 5 6 7 8 9 10 ...